Boundless Bio Ownership | Who Owns Boundless Bio?
Boundless Bio Ownership Summary
Boundless Bio is owned by 2.55% institutional investors, 11.40% insiders, and 86.06% retail investors. Fmr is the largest institutional shareholder, holding 13.86% of BOLD shares.
BOLD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Boundless Bio | 2.55% | 11.40% | 86.06% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 3.10M | 13.86% | $3.81M |
| Nextech invest | 1.23M | 5.49% | $1.51M |
| Sectoral asset management | 678.57K | 3.04% | $834.65K |
| Vanguard group | 569.66K | 2.55% | $700.68K |
| Wellington management group llp | 556.23K | 2.49% | $684.17K |
| Stonepine capital management | 413.45K | 1.85% | $508.55K |
| Alyeska investment group | 300.00K | 1.34% | $369.00K |
| Redmile group | 245.46K | 1.10% | $301.91K |
| Renaissance | 223.56K | 1.00% | $274.98K |
| Rbf capital | 200.00K | 0.89% | $246.00K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sectoral asset management | 678.57K | 0.52% | $834.65K |
| Stonepine capital management | 413.45K | 0.41% | $508.55K |
| Nextech invest | 1.23M | 0.23% | $1.51M |
| Sio capital management | 163.68K | 0.05% | $201.32K |
| Redmile group | 245.46K | 0.03% | $301.91K |
| Almitas capital | 86.81K | 0.02% | $106.77K |
| Rbf capital | 200.00K | 0.01% | $246.00K |
| Abel hall | 14.40K | 0.01% | $14.54K |
| Xtx topco | 29.08K | 0.00% | $35.77K |
| Bridgeway capital management | 50.50K | 0.00% | $62.12K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Stonepine capital management | 413.45K | 0.41% | 307.28K |
| Renaissance | 223.56K | 0.00% | 102.56K |
| Vanguard group | 569.66K | - | 88.39K |
| Geode capital management | 102.27K | - | 43.37K |
| Squarepoint ops | 50.77K | 0.00% | 32.37K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -2.18M |
| Redmile group | 245.46K | 0.03% | -343.58K |
| Pfm health sciences, lp | - | - | -240.51K |
| Almitas capital | 86.81K | 0.02% | -148.70K |
| Ubs oconnor | - | - | -140.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Abel hall | 14.40K | 0.01% | 14.40K | $14.54K |
| Optiver b.v. | 168.00 | - | 168.00 | $207.00 |
Sold Out
| Holder | Change |
|---|---|
| Eversource wealth advisors | -2.00 |
| True wealth design | -5.00 |
| Clearstead advisors | -24.00 |
| Deutsche bank ag\ | -97.00 |
| Sterling capital management | -119.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 2 | -94.87% | 569,825 | -93.58% | 2 | 0.16% | 2 | -88.24% | - | -100.00% |
| Jun 30, 2025 | 42 | -20.75% | 9,787,223 | -42.33% | 43 | 0.76% | 18 | -14.29% | 17 | 13.33% |
| Mar 31, 2025 | 5 | -90.74% | 3,986,980 | -69.24% | 17 | 0.53% | - | -100.00% | 1 | -66.67% |
| Dec 31, 2024 | 54 | 1.89% | 12,962,527 | -1.19% | 58 | 1.68% | 37 | 60.87% | 3 | -81.25% |
| Sep 30, 2024 | 53 | 12.77% | 13,118,509 | -5.23% | 58 | 1.49% | 23 | -30.30% | 16 | 100.00% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 08, 2019 | Patterson Matthew R | Chief Executive Officer | Sell | $432.78K |
| Aug 12, 2019 | Patterson Matthew R | Chief Executive Officer | Sell | $34.52K |
| Aug 12, 2019 | Patterson Matthew R | Chief Executive Officer | Sell | $646.31K |
| Feb 25, 2019 | Patterson Matthew R | Chief Executive Officer | Sell | $120.00K |
| Oct 01, 2018 | Patterson Matthew R | Chief Executive Officer | Sell | $202.73K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2020 Q1 | - | - |
| 2019 Q4 | - | 1 |
| 2019 Q3 | - | 2 |
| 2019 Q2 | - | - |
BOLD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools